Increased barrier permeability may be the first step in the development of various disorders, or be a cause of their progression, not only in gastrointestinal disease
The published data shows meaningful but modest fat loss in clinical conditions, approximately 1 to 2 kg of additional fat loss over 12 weeks compared to placebo at 1 mg/day
Research Applications Published Research Peer-reviewed studies from PubMed
If they proliferate but the FDA's ability to oversee them does not proliferate, you are going to have people who get hurt, Sklamberg says
Multiple logistic regression models were used, with presence of sepsis as the outcome variable, and HTC, B12, and MMA concentrations as predictor variables, separately, and adjusted for potential confounders
In this study, the team chose to investigate the role of a neurotransmitter called vasoactive intestinal peptide, as it has previously been linked to anti-inflammatory effects, meaning it could have a protective effect on disc tissue
